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Abstract
Background: Injuries to the human native cartilage tissue are particularly problematic because cartilage has little to
no ability to heal or regenerate itself. Employing a tissue engineering strategy that combines suitable cell sources
and biomimetic hydrogels could be a promising alternative to achieve cartilage regeneration. However, the weak
mechanical properties may be the major drawback to use fully degradable hydrogels. Besides, most of the fully
degradable hydrogels degrade too fast to permit enough extracellular matrix (ECM) production for neocartilage
formation. In this study, we demonstrated the feasibility of neocartilage regeneration using swine articular
chondrocytes photoencapsualted into poly (ethylene glycol) dimethacrylate (PEGDM) copolymer hydrogels
composed of different degradation profiles: degradable (PEG-LA-DM) and nondegradable (PEGDM) macromers in
molar ratios of 50/50, 60/40, 70/30, 80/20, and 90/10.
Methods: Articular chondrocytes were isolated enzymatically from juvenile Yorkshire swine cartilage. 6 × 107 cells
cells were added to each milliliter of macromer/photoinitiator (I2959) solution. Nonpolymerized gel containing the
cells (100 μL) was placed in cylindrical molds (4.5 mm diameter × 6.5 mm in height). The
macromer/photoinitiator/chondrocyte solutions were polymerized using ultraviolet (365 nm) light at 10 mW/cm2
for 10 mins. Also, an articular cartilaginous ring model was used to examine the capacity of the engineered
cartilage to integrate with native cartilage. Samples in the pilot study were collected at 6 weeks. Samples in the
long-term experimental groups (60/40 and 70/30) were implanted into nude mice subcutaneously and harvested at
6, 12 and 18 weeks. Additionally, cylindrical constructs that were not implanted used as time zero controls. All of
the harvested specimens were examined grossly and analyzed histologically and biochemically.
Results: Histologically, the neocartilage formed in the photochemically crosslinked gels resembled native articular
cartilage with chondrocytes in lacunae and surrounded by new ECM. Increases in total DNA, glycosaminoglycan,
and hydroxyproline were observed over the time periods studied. The neocartilage integrated with existing native
cartilage.
Conclusions: Articular cartilage generation was achieved using swine articular chondrocytes photoencapsulated in
copolymer PEGDM hydrogels, and the neocartilage tissue had the ability to integrate with existing adjacent native
cartilage.
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Background
Lesions in the knee joint surface are commonly treated
with microfracture [1], autologous cell implantation (ACI)
[2], or osteoarticular autograft transfer system (OATS) [3].
Although patients have symptomatic relief, there is little
convincing histological or biochemical data to support the
contention that the new tissue that forms is characteristic
of native hyaline cartilage found on the joint surface that
is composed predominantly of type II collagen. ACI and
microfracture most often result a fibrous cartilage repair
that is high in type I collagen and not durable in weight
bearing positions over the long term. Roberts et al. have
reported that as many as 65 % of second look biopsies
showed fibrocartilage [4]. Recent publications including a
meta-analysis suggest there are no differences among ACI,
microfracture, and OATS [5, 6]. Newer modifications of
the ACI technique being tested in Europe involve an open
weave or sponge matrix (MACI), frequently made from
collagen or hyaluronic acid, where the cells are absorbed
into the matrix before being secured in the lesion [7].
These woven type scaffolds do not provide any immediate
biomechanical integrity and can be crushed by the forces
placed on the joint. Furthermore, recent results suggest
that the new tissue formed is fibrocartilage and the fate of
the cells is unknown [8, 9]. Although MACI techniques
also relieve pain, the long-term results using MACI are
not yet available [10–12]. Similarly, the long-term clinical
results for cartilage regeneration employing particulated
juvenile allogeneic cartilage (DeNovo NT, Zimmer,
Warsaw, IN) and the cartilage autograft implantation sys-
tem (CAIS, Johnson & Johnson, New Brunswick, NJ) are
not fully known [13–15]. In summary, the long-term out-
comes of many cartilage restorative procedures are unsat-
isfactory and an improved method for joint surface repair
is a clear unmet need in orthopaedic surgery.
Tissue engineering strategies combining chondrocytes or
chondrocyte progenitor cells with biomimetic scaffolds
made of natural or synthetic biomaterials could be a
promising alternative for cartilage repair and regeneration.
New cartilage matrix has been successfully produced in
immunocompromised animals with cells placed on open
fibrous scaffolds, such as collagen or polyesters, but these
open lattice networks also permit invasion of inflammatory
cells in immune competent animal models that can nega-
tively affect matrix formation [16]. Hydrogels have high
water content and can be modified to have diverse physical
properties for use in medical implants, biosensors, and
drug-delivery devices [17]. Prior to polymerization, hydro-
gels can be injected in a minimally invasive manner to fill
defects of any size and shape [18–20]. Chondrocytes or
chondroprogenitors can be homogenously suspended in a
three-dimensional hydrogel, where the encapsulated cells
can retain a rounded morphology that may induce or
sustain a chondrocytic phenotype. The porous nature of
hydrogels permits the transport of nutrients and waste.
They also permit the translation of mechanical loads to en-
capsulated cells, similar to normal physiological conditions
[21]. Although mechanically weak gels may be a drawback,
the mechanical properties can be changed by crosslinking
chemistry [22]. Besides, many degradable hydrogels de-
grade too fast to permit sufficient ECM production for
neocartilage formation. Nonetheless, various research
groups including ours have successfully demonstrated
neocartilage tissue formation using multiple kinds of
hydrogels to encapsulate chondrocytes or mesenchymal
stem cells [23–28].
Poly(ethylene glycol) (PEG) is a linear carbon polymer
that can be photochemically crosslinked into a stable
hydrogel in which the biochemical and biophysical proper-
ties can be custom designed to obtain desirable properties
that permit controlled cartilage matrix production. Our
previous work has described a photocrosslinkable hydrogel
for cell encapsulation using PEG polymer [21, 29]. PEG has
a long history in medical applications with desirable chem-
istry that allows easy chemical modification. For example,
the PEG polymer chain can be methacrylated and referred
to as PEG diacrylate (PEGDM). In the presence of a photoi-
nitiator (Igracure 2959, BASF Corp., Florham Park, NJ) and
ultraviolet light (365 nm), the PEGDM forms crosslinks be-
tween the linear chains and forms a hydrogel. The polymers
and gelation process allow easy placement into joint lesions
and provide mechanical and structural stability during the
regeneration process with desirable transport properties
[30]. Previous work has shown that both the amount and
distribution of extracellular matrix (ECM) by chondrocytes
encapsulated in photopolymerized PEG hydrogels in vitro
is directly correlated to the pore size, degradation rate, and
swelling behavior of the gel networks [30–33]. When the
network mesh pore size is too small (low swelling), the dis-
tribution of large ECM molecules (e.g. glycsosaminogly-
cans) is confined to the pericellular region. By increasing
the pore size, the GAG molecules can diffuse throughout
the intercellular spaces [32]. Additionally, the degradation
properties of the PEG hydrogels (controlled by cross-
linking density) can also affect the distribution of ECM.
When chondrocytes are encapsulated in nondegradable
PEG hydrogels, the collagen molecules are confined to the
pericellular area, whereas the collagen is dispersed evenly
into the void volume between the cells in gels that are
designed to biodegrade [33]. The degradation characteris-
tics can be tailored to make gels that degrade rapidly or
slowly over time depending on the amount of degradable
lactide units grafted to the PEG. Creating gels that have
bimodal degradation could allow the scaffolds to retain
their architecture during the tissue formation and remodel-
ing processes.
Based on our earlier work on the degradation kinetics of
copolymer gels, several candidate mixtures were tested in
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preliminary studies to formulate favorable PEGDM
copolymer hydrogels that supported chondrocyte survival
and growth, and allowed new matrix production [34]. We
selected a degradable poly(ethylene glycol)-4,5 lactic acid
dimethacrylate (PEG-LA-DM) and nondegradable PEGDM
macromer for this study. Preliminary studies showed that
PEG-LA-DM that was fully degradable dissolved too
rapidly in vitro for the chondrocytes to make new ECM.
Thus, the PEG-LA-DM was combined with nondegradable
PEGDM in molar ratios that ranged from 90 % PEG-LA-
DM/10 % PEGDM to a 50/50 ratio. The aims of our study
were: 1) to demonstrate whether combining degradable
and nondegradable PEGDM copolymer hydrogels would
permit neocartilage formation by articular chondrocytes
photoencapsulated into the gels; and 2) to investigate if the
newly formed cartilage matrix could integrate with the
native cartilage.
Methods
The Institutional Animal Care and Use Committee of
the Massachusetts General Hospital approved all proce-
dures with animal tissues and live animals.
Chondrocyte isolation
Swine articular cartilage was harvested from knee joints of
three- to six- month-old female Yorkshire swine carcasses
that were euthanized from other approved studies in our
hospital (laboratory animal vendor: Tufts University,
Grafton, MA). The cartilage was minced into 1 mm3 pieces
and digested using 0.05 % collagenase type 2 (Worthington
Biochemical Co., Freehold, NJ) solution for 16 h at 37 °C.
After digestion the chondrocyte suspension was filtered
through a 100 μm sterile cell strainer (Becton Dickinson,
Franklin Lakes, NJ) to remove undigested debris. Cells were
centrifuged and washed three times in phosphate-buffered
saline. Using trypan blue and a hemacytometer, cell number
and viability was assessed. Only cell isolations with viability
above 90 % were used for the further experiments.
Polymer preparation
The synthesis of degradable PEG-LA-DM and nondegrad-
able PEGDM used in this study have been previously de-
scribed [34]. Briefly, the macromer combinations were
dissolved in sterile phosphate-buffered saline to a final con-
centration of 10 % (w/w). Mixed molar ratios of 50/50, 60/
40, 70/30, 80/20 and 90/10 (PEG-LA-DM:PEGDM) were
prepared for the study. 2-hydroxy-1[4-(hydroxyethoxy)
phenyl]-2-methyl-1- propanone (Igracure; I2959) was used
as the photosensitive initiator added to the polymer
solutions at a final concentration of 0.05 % (w/w).
Chondrocyte photoencapsulation
Swine articular chondrocytes were added to the macro-
mer/photoinitiator solutions at a concentration of 6 × 107
cells/mL. 100 μL of nonpolymerized gel containing the
cells was placed in each cylindrical mould measuring
4.5 mm diameter × 6.5 mm in height. The gel-cell
solutions were polymerized using ultraviolet (365 nm)
irradiation at ~10 mW/cm2 for 10 min.
Implantation and harvest
Experimental constructs were placed into subcutaneous
pockets in 5-week-old athymic male mice (nu/nu) (MGH,
Boston, MA) weighing 20–25 g and housed in a pathogen
free facility. The animals were exposed to a 12 h light–dark
cycle and allowed free access to sterile water and standard
mouse chow. In a sterile biosafety cabinet the animals were
anesthetized with an intraperitoneal injection of Avertin
(250 mg/kg). A one centimeter incision was made through
the skin on the dorsum of the mice and lateral subcutane-
ous pockets were made with blunt scissor dissection. The
cell-scaffold implants were inserted into the pockets. The
wound was infiltrated with 0.5 mL of sterile 0.5 % Bupivi-
caine for analgesia. At the time of specimen harvest the
animals were euthanized by exposure to carbon dioxide
from a gas source according to the recommendations of
the American Veterinary Medical Association and death
was confirmed by lack of breathing and heart beat.
A pilot study was performed in which implants from
the five different polymer ratios (4/test polymer ratio)
were made and implanted for 6 weeks. The results from
the pilot study permitted us to focus only on the poly-
mer ratios in which the matrix was contiguous and the
construct volume was highest upon harvest. The full
study focused only on ratios of 60/40 and 70/30. The
sample size was 32 specimens for each polymer mixture.
At 6, 12, and 18 weeks after implantation, eight speci-
mens from each group were harvested. Specimens were
evaluated for macroscopic appearance, weighed, and
randomly selected for either histological examination or
biochemical analyses (DNA; glycosaminoglycan (GAG);
hydroxyproline). An additional 8 samples were prepared
for each polymer mixture, but were not implanted for
use as controls for assays at time zero.
Ring model preparation
A previously published model using cartilage rings was
used to study the integration of the engineered cartilage
with existing cartilage matrix [35]. Using an 8 mm punch
biopsy, disks of swine articular cartilage were made measur-
ing 8 mm × 2 mm. Using a 5 mm biopsy punch, the center
of the cartilage disk was removed leaving a ring of native
cartilage matrix. To eliminate any influence on healing and
integration by the chondrocytes in the rings, they were
devitalized using five freeze–thaw cycles. Gel solution
containing the chondrocytes cells was placed into the cen-
tral cavities of the disks and photopolymerized. The ring
model constructs were examined grossly and processed for
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histology to evaluate the interface between the native cartil-
age ring and the new cartilage formed in the copolymer gel.
Specimen evaluation
Specimens in the pilot study were harvested at 6 weeks
to assess the volume and cartilage forming ability among
the various ratios of the copolymers. The dimensions
and wet weight of the specimens were recorded. These
specimens from the pilot study were only evaluated by
histology. Samples were fixed in 10 % buffered formalin
for a minimum of 24 h and embedded in paraffin. Serial
5 mm sections were made, deparaffinized, and stained
with hematoxylin and eosin (H&E).
Specimens in the full study comparing 60/40 and 70/30
polymer ratios were collected after 6, 12, and 18 weeks in
vivo. The specimens were cut in half with one-half used
for biochemical assays and the remaining half for histo-
logical processing. In addition to H&E staining to evaluate
overall tissue morphology, histological sections were
stained with safranin O to assess proteoglycan content of
the neotissue. Sections also were immunostained with
antibodies against collagen types I and II (Chondrex,
Redmond WA). Briefly, slides were treated with 2 % bo-
vine testicular hyaluronidase at room temperature for
30 min. A blocking reagent consisting of 0.3 % hydrogen
peroxide in methanol was added for another 30 min
followed by 10 % goat serum for 30 min. On separate test
slides, antibodies against collagen type I and type II were
applied for 1 h. N-Universal Negative Control was applied
for the negative control, and the secondary horseradish
peroxidase (HRP) labelled antibody was added for 20 min.
3,3-diaminobenzidine was applied to each slide to react
with the HRP, and the sections were counterstained with
hematoxylin.
Samples of native articular swine cartilage and portions
of the experimental samples were analyzed biochemically.
The specimens were weighed to obtain the wet weight of
the samples then lyophilized. After lyophilization, the dry
weight of the specimens was recorded, and the difference
between the wet and dry weights was the water content of
the neotissue. Papain type III solution (Sigma-Aldrich, St.
Louis, MO) at 125 mg/mL was added to the lyophilized
specimens to digested the cartilage matrix for 16– 24 h at
60 °C. A PicoGreen dsDNA Quantitation Assay Kit
(Molecular Probes, Eugene, Oregon) was used to determine
the amount of DNA or cells in the specimens. A standard
curve of Lambda DNA from the kit was generated. The
amount of DNA from the test specimens was determined
and used as an indicator of the proliferative potential of the
photoencapsulated chondrocytes. A previously published
dimethylmethylene blue dye method was employed to
measure the amount of GAG in the specimens using chon-
droitin sulfate B (Sigma-Aldrich) as a standard in the inter-
pretation of the data [36]. The amount of hydroxyproline in
the tissues served as a surrogate marker for total collagen.
Hydroxyproline was quantified using a previously published
method using L-4- Hydroxyproline (Fluka Biochemika,
Steinleim, Switzerland) as the standard [37]. All the DNA,
GAG, and hydroxyproline data were normalized by wet
tissue weight.
Statistical analysis
Quantitative data of the study was statistically analyzed
using a Student t-test (Sigmastat 2.0, SPSS Science,
Chicago, IL) and ANOVA. All the values are reported as
the mean ± standard deviation and the level of statistical
significance was set at p < 0.05.
Results
Pilot study results
The volumes of the five different polymer ratios from
the pilot study are shown in Fig. 1. Only specimens
made with 60/40 and 70/30 retained greater than 90 %
of the volume that was originally implanted. The histo-
logical results from the group made from 50/50 polymer
showed isolated cells with small amounts of pericellular
matrix surrounded by large areas of remaining PEG gel
(Fig. 2). Specimens made from high amounts of degrad-
able polymer, 80/20 and 90/10, had islands of cartilage,
but large void spaces in between the cartilage areas.
Specimens made with ratios of 60/40 and 70/30 demon-
strated nearly contiguous cartilage matrix and were the
focus of further study.
Gross evaluation
The results for the full study are shown in Table 1. At
6 weeks there was a reduction in average wet weight in
both copolymer hydrogel groups compared with the time
zero control samples (p < 0.05 for 60/40 group and there’s
no statistical difference for 70/30 group). However, the
average wet weight of the specimens was higher than the
initial weight in both groups by 18 weeks (p < 0.01). A
reduction in average volume was observed at 6 weeks in
Fig. 1 Construct volume data of the preliminary study after 6 weeks
in vivo using 50/50, 60/40, 70/30, 80/20 and 90/10 ratios of
degradable/nondegradable PEG (# p > 0.05)
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60/40 copolymer hydrogel group (p < 0.05), whereas there’s
no significant reduction in volume in the 70/30 copolymer
group at the same time point. Nonetheless, the volume of
samples were higher than the initial volume in both groups
(p < 0.01) by 18 weeks. There was a very slight reduction in
average water content at 6 weeks in both copolymer groups
compared with the native cartilage control samples, and by
18 weeks, there’s slight increase in average water content in
both groups. However, there were no statistical differences
in water content among the study groups or between the
different harvest times.
At the early 6-week time point the samples remained
translucent due to the residual gel component. The 6-
week samples also were relatively soft and gel-like. As
the gel was replaced with new cartilage matrix over time,
the specimens became increasingly opaque (Fig. 3).
Biochemical evaluation
The DNA content of copolymer/cell constructs at time
zero was measured and set as 100 % for comparision of the
experimenatl implants (Fig. 4a) Specimens from both co-
polymer groups increased over time suggesting that the
cells were proliferating within the gels. By 18 weeks, the
average amount of DNA in the specimens was 184.29 ±
29.19 and 206.74 ± 32.62 for both 60/40 and 70/30 hydrogel
groups, respectively. There were no significant differences
noted among the groups over the time points studied.
The amount of GAG in the constructs increased over
time for both copolymer groups (Fig. 4b). By 18 weeks,
the amount of GAG in the 60/40 group was 35.32 ±
8.67 μg/mg of wet tissue weight, whereas it was slightly
lower in the 70/30 group, 33.46 ± 7.32 μg/mg. There was
no statistically significant difference between different
study groups at each of the harvest time points. The
amount of GAG in the engineered cartilage made with
60/40 group was 63.39 % of that in native articular car-
tilage at the 18-week time point, whereas the amount of
GAG in the 70/30 at this timegroup was 60.06 % of that
in native articular cartilage.
The amount of hydroxyproline, used as a surrogate meas-
ure of total collagen, also increased over time. The amount
of toal collagen at 18 weeks in the 60/40 group was 7.61 ±
0.60 μg/mg of wet tissue weight compared to 13.47 ±
3.95 μg/mg in native articular cartilage. Stated differently,
this was about about 56.52 % of that found in the native
cartilage. In both groups, the hydroxyproline content
(Fig. 4c) also increased over time. At the final harvest time
point, the total collagen in the 60/40 hydrogel group 7.61 ±
0.60 μg/mg of wet tissue weight compared to 13.47 ±
3.95 μg/mg of wet tissue weight in native articular cartilage,
or about 56.52 % of that found in the native cartilage. The
total collagen was slightly higher the 70/30 hydrogel group
measuring 9.52 ± 3.01 μg/mg or about 70.67 % of the
content measured in native cartilage. Both groups only
reached about one-half to two-thirds of the amount of
collagen on native articular cartilage over the time period
studied. There was no significant difference between groups
at 18 weeks, however.
Histological evaluation
Typical of the morphology found in native articular cartil-
age, chondrocytes were observed in lacunae surrounded
by basophilic extracellular cartilage matrix in histological
specimens from the engineered constructs (Fig. 5). The
specimens were hypercellular and the number of cells
nearly doubled over time of the study (Fig. 4a). The
Fig. 2 Hematoxylin and eosin-stained sections of the preliminary results demonstrated noncontiguous cartilage formation using 50/50, 60/40, 70/30,
and 80/20 ratios. (From left to right, original magnification × 100, bar: 100 μm)
Table 1 Summary of Specimen Dataa
60/40 (PEG-LA-DM/PEGDM) 70/30 (PEG-LA-DM/PEGDM)
Time 0 Controlb 6 weeks 12 weeks 18 weeks Time 0 Control 6 weeks 12 weeks 18 weeks
Wet weight (mg) 103.50 ± 4.10 91.35 ± 4.31 111.05 ± 4.59 117.90 ± 4.38 104.80 ± 8.06 100.35 ± 3.61 107.45 ± 2.57 114.30 ± 2.54
Volume (mm3) 93.54 ± 1.21 86.09 ± 3.92 96.02 ± 3.89 104.55 ± 1.32 92.92 ± 4.64 91.87 ± 1.42 93.79 ± 1.38 102.85 ± 2.37
Water content (%) 82.29 ± 3.78 79.01 ± 4.05 85.70 ± 2.45 86.09 ± 2.95 83.14 ± 3.87 80.07 ± 4.42 86.22 ± 3.17 85.61 ± 2.91
PEG-LA-DM poly(ethylene glycol)-4,5 lactic acid dimethacrylate, GAG glycosaminoglycan, HYP hydroxyproline
aAll the data are presented as mean value ± standard deviation
bTime 0 controls were specimens in which cells were encapsulated in gels and then analyzed for baseline data
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distribution of the encapsulated chondrocytes at 6 weeks
was nonhomogeneous in both study groups and the cells
appear to be somewhat hypertrophic. This may be due to
the incomplete degradation of the hydrolysable crosslinks
of the polymer scaffold at the early time point. Over time,
the new cartilage matrix became more homogeneous and
there were no discernible visual differences between the
60/40 and 70/30 groups by 18 weeks.
The results from immunohistochemistry demonstrated
that the cells encapsulated within the photopolymerized
gels could maintain their chondrocyte phenotype by produ-
cing collagen type II, typical of that found in native cartilage
(Fig. 5). At 6-weeks, the collagen type II staining was re-
stricted to the pericellular regions of the encapsulated cells,
probably because of residual polymer at this time point
(data not shown). Over time, the type II collagen staining
pattern became more homogeneous in the engineered
specimens, similar to the observation in native swine cartil-
age (Fig. 5). Little evidence of type I collagen was noted in
the specimens.
The neocartilage generated in the colpolymers was
capable of integrating with native cartilage as demonstrated
in the cartilage ring model. Devitalized cartilage rings were
used to eliminate the potential for influence by the cells
that reside in the native cartilage. Histological sections at
the interface of the engineered cartilage and native cartilage
showed integration between the tissues (Fig. 6). The cells at
the interface were ovoid and perpendicular to the surface of
the native cartilage. The engineered tissue filled irregular-
ities of various depths and shape along the interface.
Discussion
Development of effective and minimally invasive tissue
engineering techniques using injectable hydrogel materials
to support chondrocyte growth and ECM production could
be an ideal therapeutic strategy for cartilage repair and
Fig. 4 Biochemical evaluation data. (a) DNA content (b) GAG
content and (c) hydroxyproline content. ( 0w, 6w, 12w,
18w, native swine) (* p < 0.05, † p < 0.01, § p < 0.001)
Fig. 3 Macroscopic view of constructs over the implantation time for 60/40 and 70/30 ratios
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regeneration. Numerous hydrogels have been formulated
for cartilage generation including natural materials such as
fibrin, chitosan, collagen, hyaluronic acid (HA), and self-as-
sembling peptides to mention a few [19, 27, 38–40]. Syn-
thetic materials also have been developed into hydrogels
that permit encapsulation of chondrocytes and new cartil-
age matrix formation, such as poly(vinyl alcohol) and
poly(ethylene glycol) [18, 31]. Extracellular matrix compo-
nents, such as GAG or HA, or growth factors have been
added to these gels to promote cartilage formation in
some cases [41]. Most studies, however, have explored
only single, base polymer formulations and not combina-
tions thereof.
Gels can be formulated that are non-degradable and
resistant to breakdown allowing maintenance of three-
dimensional architecture. However, these resilient gels in-
hibit cell-to-cell contact and interfere with intracellular
ECM production. Data from previous studies show that
nondegradable PEGDM gels permit extracellular matrix
formation in the pericellular region, but the nondegrad-
able polymer interferes with generating contiguous cartil-
age matrix [32]. Synthesizing degradable PEG gels that
can break down within predictable periods of time can be
achieved by adding in water soluble crosslinks to the
macromer backbone. It is challenging, however, to deli-
cately time the degradation process while maintaining vol-
ume and three-dimensional shape in vivo. Photochemical
crosslinking to polymerize gels allows for molding them
into predetermined shapes permitting cartilage formation
in the desired form. Previously published in vitro data
showed that fully degradable photocrosslinked PEG-LA-
DM degraded too rapidly for cartilage matrix to form [34].
Pilot studies in vivo with this degradable formulation con-
firmed this as well. By combining nondegradable with de-
gradable PEG, we hoped to tailor the gels to form
articular cartilage yet maintain structural integrity during
tissue formation. Thus, the goal of this study was to evalu-
ate neocartilage formation employing copolymers com-
posed of a combination of degradable and nondegradable
PEG macromers.
Modifications of the polymerization process can affect
the mechanical and biological behaviors of the final
hydrogel. The amount of crosslinking has a direct im-
pact on the cartilage formation capacity of the chondro-
cytes [21], although the crosslinking process does not
negatively affect cell viability throughout the gels [30].
Also, Omobono et al. showed that secondary treatment
of photochemically crosslinked collagen gels with chem-
ical crosslinking using N-hydroxysuccinimide (NHS) and
1-ethyl-3-(3-dimethylaminopropyl)carbodiimide (EDC)
was able to slow the enzymatic degradation without
compromising cell viability [42]. In the current study, we
chose two polymer formulations that could be photopo-
lymerized simultaneously with the same photoinitiator
agent and the same wavelength of light. This unique
strategy permitted us to blend these two different PEG
formulations with the cells and polymerize them simul-
taneously into the final hydrogel promoting cartilage
matrix formation. The pilot study confirmed that gels
high in degradable PEG (80/20 and 90/10) content
dissolved too rapidly for cohesive neocartilage formation.
Formulations where the nondegradable PEG content was
50 % inhibited contiguous cartilage matrix formation due
to the resistance of the polymer to biodegradation. These
Fig. 5 Histological and an immunohistochemical results from gels made with 60/40 and 70/30 ratios of degradable/nondegradable PEG compared to
native swine articular cartilage. (Original magnification × 100, bar: 100 μm)
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results narrowed the focus of the larger study on the
photochemically crosslinked co-polymer formulations of
60/40 and 70/30.
Our data showed that the average weight and volume
of the neocartilage samples were statistically higher than
the initial values at the time of implantation for both
groups (60/40 and 70/30) at 18 weeks. The neocartilage
samples were increasingly opaque over time indicating
more ECM deposition. The changes in the biochemistry
of the ECM paralleled the changes in morphology over
time. There was a significant increase in GAG, hydroxy-
proline, and total DNA content during the 18 weeks of
study, and there were no statistical differences between
the 60/40 and 70/30 groups at each time point. Nor-
mally, articular chondrocytes in cartilage are nurished by
diffusion from the surrounding synovial fluid facilitated
by the loading patterns of the joint. Ectopic implantation
of these cells into subcutaneous space alters dramatically
their biological environment, while the nutritive ele-
ments received from the interstitial fluid and the bio-
mechanical stimuli of the joint are quite different.
The strength of the interface of the engineered cartil-
age with existing adjacent native cartilage is of great im-
portance in articular cartilage repair because weakness
at this interface could cause collapse of the new cartilage
tissue and jeopardize the cartilage restoration. Promot-
ing integration of the new and existing matrix is corre-
lated with collagen synthesis and deposition by viable
cells at the interface [43–46]. The results from this study
showed that the engineered cartilage integrated with
existing native cartilage using these copolymer hydrogel
formulations seeded with cells. Partial integration of the
neocartilage with the opposing surface of the native
cartilage was noted by 6 weeks (data not shown), but by
week 12 and 18, the integration interface showed re-
population, deposition of matrix macromolecules, and
Fig. 6 Upper row: Macroscopic view of 18 week constructs of ring model for integration study. Below each group are the toluidine blue (left) and
collagen type II (right) staining of the integration interface between the engineered cartilage (EC) and native articular cartilage (NC) related to the
above constructs. (Original magnification × 100, bar: 100 μm)
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tight adhesion between the the engineered and native
cartilage. The improved integration and the tight inter-
face junction at the later times may be related to the
breakdown of the polymer scaffold over time with the
simultaneous growth of new cartilage matrix.
Most studies evaluating polymer scaffolds seeded with
cells have been initially tested in vitro prior to pilot testing
by implantation into nude mice. Nude mice lack a reper-
toire of mature T-cells and cannot mount a cellular rejec-
tion response to allogeneic or xenogeneic cells. In many
ways they can be considered a “living” petri dish for
studying cartilage (and bone) matrix formation from cell-
seeded scaffolds. We chose a mouse model with subcuta-
neous implantation to generate neocartilage because this
permits better cartilage formation than in vitro systems.
The biomechanical microenvironment in the joint cannot
be replicated in the subcutaneous pockets on the back of
nude mice, however. We recognize that the model may
have some deficiencies, but the nude mouse is a suitable
small animal model to pilot screen and test new scaffolds
and tissue formation. Further modifications in hydrogel
chemistry or photopolymerization mechanism can im-
prove the scaffold properties of PEG derivatives for tissue
engineering of articular cartilage, particularly in terms of
the intrinsic adhesive properties. The application of these
copolymers in immunocompetent animal models will be
the focus of subsequent studies.
Conclusions
Our findings demonstrated that copolymers that are com-
posed of degradable and nondegradable PEGDMmacromers
are favorable scaffolds for engineering articular cartilage. No
obvious differences were observed among the studied copol-
ymers at different ratios (60/40 and 70/30) in the cell prolif-
eration, biochemical performance and integrative properties
between the engineered tissue and adjacent native tissue.
Potentially, a liquid macromer/chondrocyte suspension like
PEGDM copolymer could be injected into the cartilaginous
defect and photopolymerized to provide a minimally invasive
technique to promote or enhance articular cartilage repair.
Further studies are required to investigate the potential of
this tissue engineering approach for chondrogenesis involv-
ing large animal models and focusing on the biomechanical
properties of the engineered articular cartilage.
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